iShares Biotechnology ETF (NQ:IBB)

205.88 +0.59 (+0.28%)

Delayed Quote Updated: 10:03 AM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about iShares Biotechnology ETF

< Previous 1 2 3 4 5 6 7 8 9

...

28 29 Next >

Solid Biosciences' Retail Following Swells Amid Stock's Best Run In A Year — What's Behind The Move? ↗

February 18, 2025

Early-stage data from the company's gene therapy candidate SGT-003 for Duchenne muscular dystrophy (DMD) showed encouraging results.

Via Stocktwits

Biotech Stocks Had A Good Week Despite Crosscurrents ↗

February 18, 2025

It’s too early to account for the rally but in general one can say that there is a lot of speculation from both the retail side and hedge funds.

Via Talk Markets

Topics ETFs Stocks / Equities

Do The Major Sector ETFs Love High Flying Stocks? ↗

February 16, 2025

The major sector ETFs remain muted. Nothing screams wildly bullish or horribly bearish in the weekly charts.

Via Talk Markets

Topics Cryptocurrencies ETFs

Ascendis Pharma Eyes Best Open In A Month After Q4 Print, But BofA Cuts Price Target: Retail Gets Buzzing ↗

February 13, 2025

The brokerage adjusted its 2025 Yorvipath sales forecast downward, expecting a more backloaded ramp.

Via Stocktwits

Price Action Disputes Most Macro Narratives ↗

February 09, 2025

Do you believe the economy is heading towards inflation? What about a recession? Are gold prices sending a warning? Read on for the answer.

Via Talk Markets

Topics Economy Stocks / Equities

Can Biotech Stocks Survive The Precarious Macro? ↗

February 03, 2025

We were having a nice rally in January 2025 until the reality of tariffs hit on Friday which killed the momentum developing off the mid-January lows.

Via Talk Markets

Topics Stocks / Equities World Trade

Compare/Contrast - Year Of The Yin Wood Snake 1965 And 2025 ↗

February 02, 2025

The Federal debt in 1965 was $322.3 billion. In 2025 it is at $36.24 trillion. The unemployment rate was 5.2%. Now it is at 4.1%.

Via Talk Markets

Topics ETFs

Small- To Mid-Cap Biotech Trades Poised For Gains ↗

February 01, 2025

On Monday, we called for a trading bottom in healthcare stocks. We also saw momentum picking for two Health Science sectors: small- to mid-cap biotechs, and MedTech. Here is a closer look at these...

Via Talk Markets

Topics ETFs Stocks / Equities

DeepSeek Is Not New - The Rotation Away From Tech Is ↗

January 27, 2025

The technical aspect of DeepSeek is not new. The reaction to it though, is new.

Via Talk Markets

Topics Commodities

Intellia Stock Dips After Morgan Stanley Downgrade, Retail Sentiment Weakens ↗

January 27, 2025

The brokerage pointed to the company’s recent discontinuation of its NTLA-3001 program for alpha-1 antitrypsin deficiency-associated lung disease, reducing near-term growth prospects.

Via Stocktwits

Healthcare And Biotech Stocks Lag The Market Again ↗

January 20, 2025

Biotech stocks got little help from the JPM Conference despite some recovery to the general market.

Via Talk Markets

Topics Stocks / Equities

There May Still Be Time to Get in on These 3 Trending Biotechs

January 20, 2025

Biotech firms as a group declined slightly in the last year amid a tough external environment, but these three companies could grow in 2025.

Via MarketBeat

Topics ETFs Economy

Major Sector ETFs January Trend Trade is Here ↗

January 19, 2025

Transportation IYT chart is incredible. The price action Friday showed the attempt to take out the January trend trade range and then failed.

Via Talk Markets

Topics ETFs

Inflation, Soft Landing, January Trend Trade Working Out ↗

January 15, 2025

Sugar, as shown in the weekly chart, has broken down under the 200-WMA for the first time since December 2020. However, it is holding the August 2024 low.

Via Talk Markets

Topics Commodities ETFs Economy

Avadel Pharmaceuticals Misses Earnings Estimates But Posts 150% Sales Increase From Narcolepsy Drug LUMRYZ ↗

January 09, 2025

Avadel Pharmaceuticals missed the fourth quarter sales estimate by 5.12%. Still, the sales of its narcolepsy drug, LUMRYZ rose by 150% YoY.

Via Benzinga

The Major Sector ETFs Remain Technically Intact ↗

January 08, 2025

As long as XRT holds 78.00, it’s back where it broke out from after a massive consolidation last year.

Via Talk Markets

Topics Cryptocurrencies ETFs

Two Big Weeks To Play A Rally In Biotech And Healthcare Stocks ↗

January 06, 2025

The healthcare sector is lagging over the past year and recent quarter with the XLV flat for 2024 and down over 4% for the recent quarter.

Via Talk Markets

Topics ETFs Stocks / Equities

Happy New Year Or Is It For The Major Sector ETFs? ↗

January 02, 2025

Russell 2000 IWM, has a few key points of support to hold. $217 is one. The 50-week moving average at around $212.45 is another.

Via Talk Markets

Topics ETFs

Healthcare And Biotech Stocks Continue Their Slide ↗

December 30, 2024

Biotech shares continued their slide which began in early November and got no help from small caps which also sold off through December.

Via Talk Markets

Topics ETFs Stocks / Equities

Major Sector ETFs - Buy This Dip? ↗

December 15, 2024

As we ended this week, clearly Nasdaq held up better than pretty much everything else.

Via Talk Markets

Topics Commodities ETFs

The Major Sector ETFs Talk Turkey ↗

November 27, 2024

Retail XRT should hold the gap up it started this past week with. If that is the case, we anticipate a move higher for the coming week.

Via Talk Markets

Topics Currencies/Forex ETFs

Momentum Model For Trading SMID Biotech Stocks: Broad Rally Underway ↗

November 25, 2024

Biotech stocks are poised for a recovery in a seasonally strong period through January 2025.

Via Talk Markets

Topics ETFs Stocks / Equities

Major Sector ETFs - Retail Rallies ↗

November 24, 2024

What we waited for was a weekly close over 79.20, a level we have not seen since February 2022.

Via Talk Markets

Topics Cryptocurrencies ETFs

Is Biotech’s Bull Run Over? Examining Election Impacts

November 21, 2024

The biotech sector's breakout attempt post-election reversed sharply, with ETFs like IBB and XBI falling and invalidating the long-term bullish setup.

Via MarketBeat

Topics ETFs Government

Cameco, Applied Digital, West Pharmaceutical And More On CNBC's 'Final Trades' ↗

November 18, 2024

On CNBC's "Halftime Report Final Trades," Tim Seymour of Seymour Asset Management picked Cameco Corporation.

Via Benzinga

Reality Sets Into The Major Sector ETFs ↗

November 17, 2024

XRT failed to rally above the $80 level, the top of the 10-month consolidation.

Via Talk Markets

What Do Major Sector ETFs Say Now? ↗

November 10, 2024

KRE is back to the scene of the crime at the 65 level. Above there, we see 75 area as the next resistance.

Via Talk Markets

Topics ETFs

What Does the Economic Modern Family Say Now? ↗

November 10, 2024

Considering where the Economic Modern Family was just a few weeks ago, clearly euphoria has spread since the election.

Via Talk Markets

Smaller Cap Biotechs Are In Season: How Are We Doing? ↗

November 07, 2024

SMID biotech stocks still see a lot of speculative interest except for a brief sell-off on August 5 when the XBI touched $91.The XBI is near its 2024 high in the $103 range.

Via Talk Markets

Stock And Commodity Market Thoughts ↗

October 24, 2024

As the SPY corrects a bit from the recent run up to all-time highs, we still have keen eyes on other sectors.

Via Talk Markets

< Previous 1 2 3 4 5 6 7 8 9

...

28 29 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.